Tradestie Institutional Equity Comparison Engine
PRLD vs CING โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CING Overall Edge
CING Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cingulate Inc. Common Stock (CING) driven by superior Growth & Margin, Options & Structure while PRLD counters with relative strength in Momentum & Technical. Fundamentally, PRLD trades at N/M Forward P/E with -294.8% operating margin (+41.0% YoY revenue) versus CING at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, PRLD sits in BREAKDOWN (43rd %ile IV; Dealer Gamma Walls on Pro) against CING sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
PRLD N/M vs CING N/M Fwd P/E
Growth & Margin Winner
CING
Op Margin -294.8% vs 0.0% ยท YoY +41.0% vs +0.0%
Momentum & Technical Winner
PRLD
1Y +116.8% vs +35.4% ยท 52W Pos 36% vs 18%
Options & Structure Winner
CING
BREAKDOWN (43rd %ile IV) vs BREAKDOWN (16th %ile IV)
PRLD
NASDAQ
Prelude Therapeutics Incorporated
Pharmaceutical Preparations
$3.29
-3.37% 1D
Market Cap
$275.3M
1M Return
-2.8%
1Y Return
+116.78%
Forward P/E
N/M
Unified AI Score
47.5 / 100
HOLD
Tech 34.0
Fund 55.0
Flow 67.0
Mom 74.0
CING
NASDAQ
Cingulate Inc. Common Stock
Pharmaceutical Preparations
$4.72
+26.0% 1D
Market Cap
$62.5M
1M Return
+8.37%
1Y Return
+35.39%
Forward P/E
N/M
Unified AI Score
44.8 / 100
HOLD
Tech 31.0
Fund 50.0
Flow 67.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
PRLD +116.78%
CING +35.39%
Spread: +81.39 pp (PRLD Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
PRLD TTM Op. Margin: -294.8%
CING TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on PRLD vs CING. Trailing 12-month operating profitability (PRLD -294.8% vs CING 0.0%) and valuation multiples (PRLD N/M vs CING N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | PRLD | CING | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $275.3M | $62.5M | Larger Scale | PRLD |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +41.0% | +0.0% | Higher Growth | PRLD |
| Operating Margin (TTM) Profitability | -294.8% | 0.0% | Higher Margin | CING |
| Net Profit Margin Profitability | -269.8% | 0.0% | Higher Margin | CING |
| Return on Equity (ROE) Capital Efficiency | -57.7% | -198.7% | Higher ROE | PRLD |
| 52-Week Range Position Momentum | 36% ($1โ$7) | 18% ($3โ$12) | Stronger Trend | PRLD |
| Beta / 30D Volatility Risk Regime | 2.02ฮฒ ยท 74% Vol | 1.07ฮฒ ยท 121% Vol | Lower Realized Risk | PRLD |
| Unified Institutional Score Composite Signal | 47.5 / 100 (HOLD) | 44.8 / 100 (HOLD) | Higher Composite | PRLD |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full PRLD vs CING Buy Guide
PRLD
BREAKDOWN
150d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
43rd %ile
IV Regime
Balanced (25thโ60th %ile)
CING
BREAKDOWN
170d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
16th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither PRLD nor CING registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.